Everest Medicines (1952) Announces Extraordinary General Meeting on 24 February 2026

Bulletin Express02-03

Everest Medicines Limited (Stock Code: 1952) has released a notice of an extraordinary general meeting (EGM) to be held on Tuesday, 24 February 2026 at 10:00 a.m. via an online platform. Shareholders are invited to vote on several ordinary resolutions outlined in the notice dated 4 February 2026.

According to the announcement, the agenda includes: (1) approving, confirming, and ratifying the Commercialization Service Agreement and related transactions; (2) approving and confirming the grant of 530,303 awards to a key management member under the Pre-IPO ESOP; (3) approving and adopting the 2026 Share Scheme with a Scheme Mandate Limit of 10% of the total issued and outstanding shares (excluding any treasury shares) at the time of shareholder approval; and (4) conditionally approving and adopting a 0.5% Service Provider Sublimit within the 2026 Share Scheme if the preceding resolution is passed.

Shareholders who wish to exercise their voting rights must submit a form of proxy to the Company’s Hong Kong Share Registrar, Computershare Hong Kong Investor Services Limited, at least 48 hours before the meeting. The notice specifies that those appointed as proxies must have a valid email address to receive the login details for the virtual platform. The Company has stated that attendance and voting through the online platform are irrevocable once the voting session concludes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1143162492?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 17:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143162492","market":"us","top_or_hot":-1,"title":"Everest Medicines (1952) Announces Extraordinary General Meeting on 24 February 2026","media":"Bulletin Express","content":"<p>Everest Medicines Limited (Stock Code: 1952) has released a notice of an extraordinary general meeting (EGM) to be held on Tuesday, 24 February 2026 at 10:00 a.m. via an online platform. Shareholders are invited to vote on several ordinary resolutions outlined in the notice dated 4 February 2026.</p>\n<p>According to the announcement, the agenda includes: (1) approving, confirming, and ratifying the Commercialization Service Agreement and related transactions; (2) approving and confirming the grant of 530,303 awards to a key management member under the Pre-IPO ESOP; (3) approving and adopting the 2026 Share Scheme with a Scheme Mandate Limit of 10% of the total issued and outstanding shares (excluding any treasury shares) at the time of shareholder approval; and (4) conditionally approving and adopting a 0.5% Service Provider Sublimit within the 2026 Share Scheme if the preceding resolution is passed.</p>\n<p>Shareholders who wish to exercise their voting rights must submit a form of proxy to the Company’s Hong Kong Share Registrar, Computershare Hong Kong Investor Services Limited, at least 48 hours before the meeting. The notice specifies that those appointed as proxies must have a valid email address to receive the login details for the virtual platform. The Company has stated that attendance and voting through the online platform are irrevocable once the voting session concludes.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Everest Medicines (1952) Announces Extraordinary General Meeting on 24 February 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEverest Medicines (1952) Announces Extraordinary General Meeting on 24 February 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-03 17:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Everest Medicines Limited (Stock Code: 1952) has released a notice of an extraordinary general meeting (EGM) to be held on Tuesday, 24 February 2026 at 10:00 a.m. via an online platform. Shareholders are invited to vote on several ordinary resolutions outlined in the notice dated 4 February 2026.</p>\n<p>According to the announcement, the agenda includes: (1) approving, confirming, and ratifying the Commercialization Service Agreement and related transactions; (2) approving and confirming the grant of 530,303 awards to a key management member under the Pre-IPO ESOP; (3) approving and adopting the 2026 Share Scheme with a Scheme Mandate Limit of 10% of the total issued and outstanding shares (excluding any treasury shares) at the time of shareholder approval; and (4) conditionally approving and adopting a 0.5% Service Provider Sublimit within the 2026 Share Scheme if the preceding resolution is passed.</p>\n<p>Shareholders who wish to exercise their voting rights must submit a form of proxy to the Company’s Hong Kong Share Registrar, Computershare Hong Kong Investor Services Limited, at least 48 hours before the meeting. The notice specifies that those appointed as proxies must have a valid email address to receive the login details for the virtual platform. The Company has stated that attendance and voting through the online platform are irrevocable once the voting session concludes.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀","start_time":0,"source_url":"","article_id":"1143162492","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143162492","pubTimestamp":1770109654,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Everest Medicines Limited (Stock Code: 1952) has released a notice of an extraordinary general meeting (EGM) to be held on Tuesday, 24 February 2026 at 10:00 a.m. via an online platform. Shareholders...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"Everest Medicines(1952)宣布于2026年2月24日召开临时股东大会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"Everest Medicines Limited (Stock Code: 1952) has released a notice of an extraordinary general meeting (EGM) to be held on Tuesday, 24 February 2026 at 10:00 a.m. via an online platform. Shareholders are invited to vote on several ordinary resolutions outlined in the notice dated 4 February 2026.\nAccording to the announcement, the agenda includes: (1) approving, confirming, and ratifying the Commercialization Service Agreement and related transactions; (2) approving and confirming the grant of 530,303 awards to a key management member under the Pre-IPO ESOP; (3) approving and adopting the 2026 Share Scheme with a Scheme Mandate Limit of 10% of the total issued and outstanding shares (excluding any treasury shares) at the time of shareholder approval; and (4) conditionally approving and adopting a 0.5% Service Provider Sublimit within the 2026 Share Scheme if the preceding resolution is passed.\nShareholders who wish to exercise their voting rights must submit a form of proxy to the Company’s Hong Kong Share Registrar, Computershare Hong Kong Investor Services Limited, at least 48 hours before the meeting. The notice specifies that those appointed as proxies must have a valid email address to receive the login details for the virtual platform. The Company has stated that attendance and voting through the online platform are irrevocable once the voting session concludes.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1143162492","isCrawlerRequest":true}